List of insiders holdings for TG THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | WEISS MICHAEL S CEO |
2025-01-30 17:17:24 | 13,824,929 0 |
13,824,929 | Form 4 |
2 | ROSENWALD LINDSAY A MD 10% Owner |
2010-03-11 16:45:47 | 11,104,453 0 |
11,104,453 | Form 13G |
3 | Lipschutz Lester E 10% Owner |
2007-08-01 16:30:35 | 8,941,873 0 |
8,941,873 | Form 13G |
4 | Opus Point Partners LLC 10% Owner |
2012-08-28 17:30:29 | 7,159,394 0 |
7,159,394 | Form 13D |
5 | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
2021-02-10 16:49:20 | 6,361,123 0 |
6,361,123 | Form 13G |
6 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2021-02-10 16:49:20 | 6,361,123 0 |
6,361,123 | Form 13G |
7 | GIMBERT JOAN PONS Director |
2007-02-05 09:37:41 | 4,075,816 0 |
4,075,816 | Form 13G |
8 | McGuinness Michael COO & CFO |
2010-03-10 18:15:12 | 3,734,000 0 |
3,734,000 | Form 4 |
9 | WEISER MICHAEL Former Director Director |
2010-03-10 18:19:21 | 2,865,018 0 |
2,865,018 | Form 4 |
10 | LFB Biotechnologies S.A.S.U. 10% Owner |
2018-07-11 09:04:06 | 2,614,855 0 |
2,614,855 | Form 13D |
11 | FIRESTONE LEONARD MC Director |
2004-02-02 18:06:26 | 2,368,120 0 |
2,368,120 | Form 4 |
12 | ABEL DOUGLAS Director |
2010-03-10 18:06:49 | 1,429,000 0 |
1,429,000 | Form 4 |
13 | MCINERNEY TIMOTHY Director |
2010-03-10 18:02:18 | 1,311,575 0 |
1,311,575 | Form 4 |
14 | TANEN DAVID M Director |
2005-04-05 17:06:27 | 719,917 0 |
719,917 | Form 4 |
15 | Power Sean A CFO |
2025-01-30 17:15:48 | 708,111 0 |
708,111 | Form 4 |
16 | KAZAM JOSHOA A Director |
2005-04-05 16:35:29 | 653,025 0 |
653,025 | Form 4 |
17 | HARRIS ALAN G Chief Medical Officer |
2007-04-27 09:01:50 | 600,000 0 |
600,000 | Form 4 |
18 | ROSSETTOS NICHOLAS J Chief Financial Officer |
2005-08-19 16:40:24 | 567,030 0 |
567,030 | Form 4 |
19 | Steinhart Richard I Director |
2010-03-10 18:27:04 | 521,643 0 |
521,643 | Form 4 |
20 | Hoenlein Malcolm Former Director Director |
2010-03-10 18:10:59 | 467,201 0 |
467,201 | Form 4 |
21 | Hoberman Kenneth Director |
2024-06-20 18:05:55 | 264,935 0 |
264,935 | Form 4 |
22 | Echelard Yann Director |
2024-11-07 16:35:48 | 224,098 0 |
224,098 | Form 4 |
23 | MORVILLE MALCOLM Director |
2010-03-22 12:30:06 | 211,568 0 |
211,568 | Form 3 |
24 | Charney Laurence N Director |
2025-03-11 17:00:42 | 201,479 0 |
201,479 | Form 4 |
25 | HUME DANIEL Director |
2025-03-18 17:01:41 | 178,030 0 |
178,030 | Form 4 |
26 | SCHOENEBAUM MARK Director |
2018-06-28 17:00:26 | 125,949 0 |
125,949 | Form 4 |
27 | LOBELL J JAY See Footnote 1 |
2004-12-17 17:22:45 | 113,764 0 |
113,764 | Form 13G |
28 | KENNEDY WILLIAM JAMES Director |
2020-06-24 19:48:53 | 109,633 0 |
109,633 | Form 4 |
29 | Lonial Sagar Director |
2024-11-12 17:02:38 | 100,195 0 |
100,195 | Form 4 |
30 | Shimko David Director |
2010-03-22 12:34:29 | 92,313 0 |
92,313 | Form 4 |
31 | Herskowitz Neil Director |
2014-06-10 06:08:58 | 80,088 0 |
80,088 | Form 4 |
32 | Nordic Biotech Venture Fund II K/S 10% Owner |
2011-01-24 15:45:55 | 0 0 |
0 | Form 13D |